Kongress / Tagung
Veranstalter: we.CONECT Global Leaders GmbH
Referent: Henry Fuchs
Veranstaltungsseite: zur Homepage
Sprache: Englisch
Aufrufe gesamt: 23, letzte 30 Tage: 2
Veranstalter
we.CONECT Global Leaders GmbH
Telefon: +49-30-5210703-0
Preis: 2.495,-- € zzgl. gesetzl. Mwst.
Dates: 24th & 25th September 2012
Venue: Novotel Berlin am Tiergarten / Germany, Straße des 17. Juni 106, 10623 Berlin, Germany
Website: http://pharma-mes.we-conect.com
MES & Process Minds 2012 - Pharma & Life Science Industries - Improving Quality & Compliance and increasing operational excellence with manufacturing execution systems in Pharma & Life Sciences Industries
we.CONECT is bringing an international audience of global manufacturing directors from pharma & life Sciences industry to Berlin, to network, share knowledge and be made aware of the key developments within the industry.
With over 80 of the world's leading pharma & life sciences operators and suppliers, the MES & Process Minds 2012 is the definitive event for the industry.
Highlights are keynote sessions from following industry leaders:
Dr. Peter Iles-Smith MES Tecnical Director, GlaxoSmithKline plc / UK explains how you identifying the cost drivers in MES projects and shows the impact of the people dimension on cost and schedule.
Carson Sublett Vice President of Operations & Site Director, DSM Pharmaceuticals / USA shows how to deal with challenges in managing Automation & MES and to reduce complexity.
Paul Kelly MES Director Corporate Operations, Genzyme Industrial Affairs IS / Ireland presents the design, implementation, upgrade and global rollout of MES at Genzyme.
Christoph Lebl Associate Director Automation, Genentech Inc. / USA gives a lecture on system obsolescence and the road to a new MES at a biotech facility.
Dr Bernd Lehle Director Biopharma Electronic Management Systems/ Global Dep. BP Engineering & Technology, Boehringer Ingelheim Pharma GmbH & Co. KG / Germany explains the Importance of a flexible MES Architecture in a changing business environment and discuss general pharma trends: less blockbusters, more specialized drugs and more biotech and the impact of manufacturing IT.
Michele Vecchi, Head of Manufacturing Information Systems, Chiesi Group / Italy shows how a mid-sized company has achieved an additional competitive advantage through the tight integration of their EBR / MES and their Automation System.
Laura Lei, Director Global Technology, Baxter BioScience / USA will give at the World Café a statement to “Process & Manufacturing IT harmonization of multiple sites to improve product quality and achieve excellence in manufacturing operations”.
Listen to more than 20 industry case studies and discuss at various roundtables cutting edge topics in the field of manufacturing execution systems!
Delegates will come from over 20 countries, take full advantage and attend at
Several Ice Breaker , interactive roundtables as part of a World Café and case studies of well-known companies to provide participants an overview of strategies, best practices and solutions as cutting edge topics as well.
According to Daniel Wolter, Head of Partnerships, we.CONECT Global Leaders, the conference aim is to provide participants a balanced mix of lectures and many opportunities as possible to discuss viable approaches for managing MES and IT in manufacturing plants.
It is now time to expand the level of integration and automation further to a more flexible manner to respond to changing market demands.
At the MES & Process Minds 2012 you will discuss challenges and solutions in managing MES for pharma & life sciences industry with peers from all over Europe.
Individuals interested in attending, sponsoring or finding out more about MES & Process Minds 2012 should visit http://pharma-mes.we-conect.com
Or contact
Thomas Krämer
Director Sales
we.CONECT Global Leaders GmbH
Gertraudenstr. 10-12 | 10178 Berlin, Germany
Phone: +49 (0)30 52 10 70 3 - 55 | Fax: +49 (0)30 52 10 70 3 - 30
Email: thomas.kraemer@we-conect.com
www.we-conect.com
Notes to Editor
About we.CONECT Global Leaders